RNF2 and neoplasm: Because of the high RNF2 level in PCa tumor tissues and the inhibited cell proliferation and increased apoptosis in RNF2 knockdown cells, we conclude that RNF2 may be used as a new biomarker for diagnosis and new target for the therapy of PCa.